A Case-Control Study to Determine If Hydroxyurea Augmentation of Antiretroviral Drug Regimens that Contain ddI and/or d4T Increases the Risk of Developing Peripheral Neuropathy in HIV-1 Infected Individuals

McCarthy, W., Gable, J., Lawrence, J., Rimland, D., & Thompson, M. (2000). A Case-Control Study to Determine If Hydroxyurea Augmentation of Antiretroviral Drug Regimens that Contain ddI and/or d4T Increases the Risk of Developing Peripheral Neuropathy in HIV-1 Infected Individuals. Pharmacoepidemiology and Drug Safety, Vol. 9, 49 - 53.